2 - Infoset
2 - Infoset
2 - Infoset
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Efficacité trithérapie/bithérapie<br />
Etudes AnE-‐protéase RVS/trithérapie RVS/Bithérapie <br />
Sprint 1 Bocéprévir 68% 40% <br />
Advance 2 Telaprévir 69 % 44 % <br />
Chez les pa>ents <br />
co-‐infectés (HIV) 3-‐4 <br />
Telaprévir <br />
74% <br />
à 24 sem. <br />
45% <br />
Bocéprévir <br />
60.7% <br />
à 12 sem. <br />
26.5% <br />
1. F Poordad et al. NEJM 2011; 364:1195-‐1206 <br />
2. IM Jacobson et al. NEJM 2011; 364:2405-‐2416 <br />
3. Dieterich D, et al. 19th CROI; Seadle, WA; March 5-‐8, 2012. Abst. 46. <br />
4. Sulkowski M, et al.; 19th CROI 2012. Abst. 47 <br />
Cours_Fordd_2013_E.Castro <br />
53
Change language